Universal Ibogaine Inc
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. The company also undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine Inc. is headquartered in Calgary, Canada.
Universal Ibogaine Inc (IBOGF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of April 2025: -0.405x
Based on the latest financial reports, Universal Ibogaine Inc (IBOGF) has a cash flow conversion efficiency ratio of -0.405x as of April 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-110.36K) by net assets ($272.17K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Universal Ibogaine Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Universal Ibogaine Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Universal Ibogaine Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Universal Ibogaine Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
RFG Holdings Ltd
JSE:RFG
|
0.121x |
|
HB Global Ltd
KLSE:5187
|
0.002x |
|
Ttbio Corp.
TWO:6493
|
-0.003x |
|
Energoaparatura S.A.
WAR:ENP
|
0.353x |
|
Bioalpha Holdings Bhd
KLSE:0179
|
-0.073x |
|
Gromutual Bhd
KLSE:9962
|
-0.015x |
|
Matinas BioPharma Holdings Inc
NYSE MKT:MTNB
|
-0.228x |
|
Sonim Technologies Inc
NASDAQ:SONM
|
10.034x |
Annual Cash Flow Conversion Efficiency for Universal Ibogaine Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Universal Ibogaine Inc from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-07-31 | $991.11K | $-838.61K | -0.846x | -35.07% |
| 2023-07-31 | $1.75 Million | $-1.10 Million | -0.626x | +43.00% |
| 2022-07-31 | $3.94 Million | $-4.33 Million | -1.099x | +0.45% |
| 2021-07-31 | $2.94 Million | $-3.25 Million | -1.104x | +14.13% |
| 2020-07-31 | $94.89K | $-121.98K | -1.286x | -251.97% |
| 2019-07-31 | $197.12K | $-71.99K | -0.365x | +66.34% |
| 2018-07-31 | $295.22K | $-320.34K | -1.085x | -- |